metricas
covid
Annals of Hepatology Pirfenidone limits the progression of malignancy and slows the development of fi...
Journal Information

Statistics

Follow this link to access the full text of the article

Pirfenidone limits the progression of malignancy and slows the development of fibrosis in experimental hepatocarcinoma.
Scarlet Arceo-Orozco1, Fernando Caloca-Camarena1, Roberto Flores-Peña1, Marina Galicia-Moreno1, Hugo Christian Monroy-Ramírez1, Juan Armendáriz-Borunda1,2
1 Institute of Molecular Biology in Medicine and Gene Therapy, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara, Mexico
2 School of Medicine and Health Sciences, Tecnológico de Monterrey Guadalajara Campus, Zapopan, Mexico
Read
364
Times
was read the article
85
Total PDF
279
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 14 0 14
2025 11 38 27 65
2025 10 26 13 39
2025 9 21 11 32
2025 8 35 13 48
2025 7 45 6 51
2025 6 56 3 59
2025 5 44 12 56

Follow this link to access the full text of the article